Showing 381-390 of 2075 results for "".
What's the last show you binge-watched?
https://practicaldermatology.com/topics/general-topics/whats-the-last-show-you-binge-watched/19875/Nazanin Saedi, MD tells us which show made her laugh and how she can't wait for the next season!Emerging Regenerative Therapies
https://practicaldermatology.com/topics/skin-cancer-photoprotection/emerging-regenerative-therapies/19643/Regenerative medical therapies, particularly PRP, are emerging as safe and efficacious therapies in dermatology. Gary Goldenberg, MD offers an overview.Minimally Invasive Trends
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/minimally-invasive-trends/19055/Michael H. Gold, MD talks about the latest trends in minimally invasive procedures, including for rejuvenation of the neck.Patient Portals
https://practicaldermatology.com/topics/practice-management/patient-portals/19113/Michael J. Sacopulos, JD, Founder and President of Medical Risk Institute (www.medriskinstitute.com), addresses the role, benefits, and potential pitfalls of patient portals.Journal Club: Dupilumab and Atopic March
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-dupilumab-and-atopic-march/32405/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Peter Lio, MD, discuss recent research indicating a reduced risk of atopic march in pediatric atopic dermatitis patients on dupilumab.Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. ReducedJoin Us for NewDerm LIVE: Welcome from the Chairs
https://practicaldermatology.com/topics/practice-management/join-us-for-newderm-live-welcome-from-the-chairs/18920/Join us September 18-20, 2015 at the W Hollywood, CA for NewDerm Live, the meeting that's focused on you—so you can focus on your future. Program chairs Sabrina Fabi, MD, Peter Lio, MD, and Kavita Mariwalla, MD, talk about the goals of the meeting and explain why they decided to be part of this exciScientifically Speaking: Can We Conquer Cellulite?
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-can-we-conquer-cellulite/19872/Treating cellulite has been a challenge, but new and emerging technologies offer hope to overcome this common condition. Host Joel L. Cohen, MD talks with Nazanin Saedi, MD, Endo's Mike McLane, PhD, and Soliton's Wally Klemp.Journal Club: Treating Itch and Lessons from the IL-4 and IL-13 Blockade
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-treating-itch-and-lessons-from-the-il-4-and-il-13-blockade/27025/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, chats with dermatologist Matthew Zirwas, MD, about how evaluations of itch can lead to treatment for atopic dermatitis, and his Journal of Drugs in Dermatology article "Unexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade."New Thinking: Eczema as a Systemic Disease
https://practicaldermatology.com/topics/psoriasis/new-thinking-eczema-as-a-systemic-disease/18756/By Seemal R. Desai, MD and Emma Guttman, MD, PhD, FAADEczema is an immune-driven disease like psoriasis. How is that knowledge changing the way that dermatologists treat patients? Are similar changes taking place for other inflammatory diseases? Dr. Guttman talks about the latest.I decided to become a dermatologist when...
https://practicaldermatology.com/topics/practice-management/i-decided-to-become-a-dermatologist-when-/18683/PD Asks Andrew Menkes, MD when he decided to be a dermatologist. Hear how he settled on a speciality that "in those days...wasn't so glamorous." In fact, Dr. Menkes says he didn't even tell some peers about his residency. Watch other responses to this question: Yolanda Lenzy, MD, MPH